Showing results (471-480 of 511) with videos related to
Sort By:
Pageof 52
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 30, 2018
Activation of RANK/RANKL/OPG Pathway Is Involved in the Pathophysiology of Fibrous Dysplasia and Associated With Disease BurdenLuis F de Castro, Andrea B Burke, Howard D Wang, et al.Journal of the American Society of Nephrology : JASN|December 24, 1997
Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlationR B Colvin, A H Cohen, C Saiontz, et al.Msphere|July 6, 2026
Enteric populations of Escherichia coli are likely to be resistant to phages due to O antigen expressionBrandon A Berryhill, Teresa Gil-Gil, Kylie B Burke, et al.The Journal of Pain|February 1, 2015
Quality of pain intensity assessment reporting: ACTTION systematic review and recommendationsShannon M Smith, Matthew Hunsinger, Andrew McKeown, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2012
U.S. Food and Drug Administration approval: ruxolitinib for the treatment of patients with intermediate and high-risk myelofibrosisAlbert Deisseroth, Edvardas Kaminskas, Joseph Grillo, et al.The Journal of Chemical Physics|February 3, 2018
SSAGES: Software Suite for Advanced General Ensemble SimulationsHythem Sidky, Yamil J Colón, Julian Helfferich, et al.Patient Education and Counseling|June 18, 2010
Health literacy, numeracy, and interpretation of graphical breast cancer risk estimatesSandra M Brown, Julie O Culver, Kathryn E Osann, et al.The Journal of Pain|February 10, 2015
Instruments to Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: An ACTTION Systematic ReviewShannon M Smith, Florence Paillard, Andrew McKeown, et al.Pain|November 27, 2013
Reporting of primary analyses and multiplicity adjustment in recent analgesic clinical trials: ACTTION systematic review and recommendationsJennifer S Gewandter, Shannon M Smith, Andrew McKeown, et al.The Journal of Biological Chemistry|June 11, 1998
Osteoprotegerin is a receptor for the cytotoxic ligand TRAILJ G Emery, P McDonnell, M B Burke, et al.Pageof 52